Mylan Laboratories Rejects Icahn #39;s \$4.9 Billion Buyout Bid The board of Mylan Laboratories rebuffed the financier Carl C. Icahn #39;s bid to buy the company yesterday, saying it remained committed to acquiring the brand-name drug maker King Pharmaceuticals.